Centre Hospitalier Régional Universitaire de Brest
Centre Hospitalier Régional Universitaire de Brest
Funder
19 Projects, page 1 of 4
assignment_turned_in ProjectFrom 2007Partners:UNIVERSITE DE RENNES I, Centre Hospitalier Régional Universitaire de Brest, Mauna Kea Technologies (France)UNIVERSITE DE RENNES I,Centre Hospitalier Régional Universitaire de Brest,Mauna Kea Technologies (France)Funder: French National Research Agency (ANR) Project Code: ANR-06-TECS-0013Funder Contribution: 824,887 EURmore_vert assignment_turned_in ProjectFrom 2007Partners:Centre Hospitalier Régional Universitaire de Brest, CNRS DELEGATION REGIONALE PARIS A, COMMISSARIAT A L ENERGIE ATOMIQUE CENTRE DE SACLAY, UNIVERSITE PARIS VI - PIERRE ET MARIE CURIE, COMMISSARIAT A L'ENERGIE ATOMIQUE (C.E.A.) - CENTRE D'ETUDE NUCLEAIRE DE CADARACHE +1 partnersCentre Hospitalier Régional Universitaire de Brest,CNRS DELEGATION REGIONALE PARIS A,COMMISSARIAT A L ENERGIE ATOMIQUE CENTRE DE SACLAY,UNIVERSITE PARIS VI - PIERRE ET MARIE CURIE,COMMISSARIAT A L'ENERGIE ATOMIQUE (C.E.A.) - CENTRE D'ETUDE NUCLEAIRE DE CADARACHE,HAPTION SAFunder: French National Research Agency (ANR) Project Code: ANR-06-ROBO-0003Funder Contribution: 537,153 EURmore_vert assignment_turned_in ProjectFrom 2008Partners:ENVOYER A GESTIONNAIRE, INSTITUT TELECOM, Centre Hospitalier Régional Universitaire de BrestENVOYER A GESTIONNAIRE,INSTITUT TELECOM,Centre Hospitalier Régional Universitaire de BrestFunder: French National Research Agency (ANR) Project Code: ANR-07-TECS-0013Funder Contribution: 286,206 EURmore_vert assignment_turned_in ProjectFrom 2009Partners:Centre Hospitalier Régional Universitaire de Brest, UNIVERSITE DE BRETAGNE OCCIDENTALECentre Hospitalier Régional Universitaire de Brest,UNIVERSITE DE BRETAGNE OCCIDENTALEFunder: French National Research Agency (ANR) Project Code: ANR-08-ETEC-0005Funder Contribution: 215,717 EURmore_vert Open Access Mandate for Publications assignment_turned_in Project2017 - 2022Partners:University of Limpopo, University of Manchester, Centre Hospitalier Régional Universitaire de Brest, NTU, University of Sussex +2 partnersUniversity of Limpopo,University of Manchester,Centre Hospitalier Régional Universitaire de Brest,NTU,University of Sussex,UAntwerpen,Makerere UniversityFunder: European Commission Project Code: 733356Overall Budget: 5,902,040 EURFunder Contribution: 5,902,040 EURThe overall research objective of the SPICES project is to implement and evaluate a comprehensive CVD prevention and control program in five settings: a rural & semi-urban community in a low-income country (Uganda), middle income (South Africa) and vulnerable groups in three high-income countries (Belgium, France and United Kingdom) as well as to identify and compare the barriers and facilitators across study contexts. The project will be evaluated using a mix of formative assessments; pre/post and trial designs. At the beginning of the project, we will conduct baseline assessments including literature reviews, formative studies, household surveys (where feasible) and learn lessons from other projects to understand healthcare and lifestyle practices, barriers, and facilitators. A cost-effectiveness and cost benefit analysis will be included. In addition, the teams will conduct site exchanges visits to learn from each other and organise policy dialogues to ensure sustainability and maximise impact of the interventions. The implementation outcomes—acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, coverage, and sustainability will be evaluated – in order to understand the factors affecting the implementation, the processes, and the accruing results. The intervention of the SPICES project will aim to: (1) improve patients ’risk profiles (LDL-cholesterol, blood pressure, HbA1c (among patients with diabetes), modify lifestyles (diet and exercise and smoking cessation) and achieve recommended cholesterol, blood pressure and glycaemic control targets; (2) increase proportion of patients receiving appropriate BP, cholesterol and diabetes medication; (3) and mitigate the number of people developing complications such a stroke and myocardial infarction.
more_vert
chevron_left - 1
- 2
- 3
- 4
chevron_right
